ANAT NURSELLA

Anat Nursella is a highly respected Venture Partner at OrbiMed, one of the world's largest and most active healthcare-dedicated investment firms. In this pivotal role, Ms. Nursella is instrumental in shaping OrbiMed's investment strategy and identifying promising opportunities within the dynamic life sciences industry. Her work involves deep dives into emerging technologies and disruptive business models that have the potential to significantly impact patient care and global health outcomes.

Ms. Nursella's investment focus at OrbiMed spans a broad spectrum of healthcare sub-sectors. She is particularly interested in biotechnology, pharmaceuticals, medical devices, diagnostics, and digital health solutions. Her expertise lies in evaluating companies from early-stage development through commercialization, assessing their scientific merit, market potential, and operational capabilities. She actively seeks out innovative companies that are developing novel therapies, advanced medical technologies, or transformative healthcare services designed to address unmet medical needs.

Prior to her tenure as a Venture Partner at OrbiMed, Anat Nursella built a robust career marked by significant contributions across various facets of the life sciences sector. While specific details of her early career are not publicly detailed, professionals in her position typically bring a wealth of experience from roles in research and development, corporate strategy, business development, or prior venture capital and private equity endeavors within healthcare. This background equips her with a comprehensive understanding of the scientific, clinical, regulatory, and commercial challenges inherent in bringing new healthcare innovations to market. Her strategic insights are invaluable to OrbiMed's portfolio companies, guiding them through critical growth phases.

As a key member of the OrbiMed team, Ms. Nursella contributes to the firm's impressive track record of successful investments. While individual notable investments are typically attributed to the firm's collective efforts, her role involves actively sourcing, evaluating, and supporting companies that become part of OrbiMed's diverse portfolio. Her commitment to fostering innovation and her deep industry knowledge make her a vital asset in OrbiMed's mission to invest in the future of healthcare globally.